Key Takeaways
- • HarbourVest's seventh flagship co-investment fund, HCF VII, recently held a final close of $4.75bn, according to PEI Private Equity.
- • HarbourVest partners Joel Hwang and Jackie Peradotto outlined the firm's plans for deploying the fund, with a focus on AI and healthcare innovation.
- • The article is tagged under Healthcare, Europe, North America and the US, reflecting the fund's cross-regional sector focus.
Summary
HarbourVest has outlined its investment approach for HCF VII, its seventh flagship co-investment fund, which recently held a final close of $4.75bn, according to PEI Private Equity. The report, written by John R Fischer, presents comments from HarbourVest's Joel Hwang and Jackie Peradotto on how the firm plans to deploy the capital.
The central theme of the discussion is the firm's interest in transformative trends in artificial intelligence and healthcare innovation. The primary source frames these as the focus areas for the fund's deployment strategy, positioning the vehicle as a co-investment platform in the healthcare sector.
The article's sector and regional tagging points to a fund with exposure across Europe, North America and the US. Because the available source material for this story is limited to the publisher summary and the article's opening, further details on specific target companies, deal pipeline or fee terms are not available in this summary.
The central theme of the discussion is the firm's interest in transformative trends in artificial intelligence and healthcare innovation. The primary source frames these as the focus areas for the fund's deployment strategy, positioning the vehicle as a co-investment platform in the healthcare sector.
The article's sector and regional tagging points to a fund with exposure across Europe, North America and the US. Because the available source material for this story is limited to the publisher summary and the article's opening, further details on specific target companies, deal pipeline or fee terms are not available in this summary.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.